NYSE · HTT

High Templar Tech Limited

$2.43 -$0.08 (-3.19%) 1D After hours

Key Metrics

$389.76M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow $81.57M
Beta · 1Y 1.09
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 25
    The stock moved -23.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 25
  • May 26
    The stock moved +23.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 26
  • Mar 31
    From its Jan 29 high, the share price fell 35%.

    Peak close $2.98 on Jan 29; trough close $1.94 on Mar 31. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -35%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$389.76M
Enterprise value
Shares outstanding155.3M
52-wk range$1.88 – $4.03
Avg volume · 20D229.1K
Net cash
Book value / share$10.71
ExchangeNYSE
About High Templar Tech Limited
IPO dateOct 18, 2017
Employees101

High Templar Tech Ltd is an enabler of financial technology. High Templar is focusing on exploring business opportunities globally to satisfy clients' demand by leveraging its technology know-how and financial service capabilities.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF4.78
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio5.75
Quick ratio5.72
Debt / equity
Debt / EBITDA
Net cash
Working capital$1.35B

Cash Flow · TTM

Operating CF $98.25M
Capex −$16.68M
Free cash flow $81.57M
Buybacks $42.97M
Dividends paid
Shareholder yield 11.0%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings